Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling
Clinical trial NCT04710056 · AVAILABLE
Trial details
- NCT number
- NCT04710056
- Sponsor
- Regeneron Pharmaceuticals
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.